X
25Aug

Johnson & Johnson Announces Acquisition of Momenta For $6.5 Billion

Goodwin | | Return|
Johnson and Johnson announced that it has entered into an agreement to acquire Momenta Pharmaceuticals, Inc. for $6.5 billion. The acquisition gives J&J’s Janssen unit full global rights to Momenta’s nipocalimab (M281), an anti-FcRn antibody designed to treat a number of autoantibody-driven disorders, including generalized myasthenia gravis (gMG), warm autoimmune hemolytic anemia (wAIHA), and hemolytic disease of the fetus and newborn (HDFN)....
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/johnson-johnson-announces-acquisition-18211/

Related

Salary Increase for White-Collar Overtime Exemption Takes Effect January 1

Last week, the U.S. Department of Labor’s Wage and Hour Division adopted final regulations revising...

Read More >

As Coronavirus Spreads, Businesses Must Be Prepared for a Crisis All Their Own

Three Critical Steps for Ensuring Business Continuity - As of today, there are reportedly more tha...

Read More >

US immigration developments: H-1B registration deadline, expansion of travel ban and impact of Coronavirus

In light of several recent immigration-related developments, we are providing an update on the follo...

Read More >

Protecting Your Most Valuable Assets: How to Identify and Maintain Your Institution’s Trade Secrets

An institution’s trade secrets generally include confidential information with commercial value. Tr...

Read More >

North Liberty Police Department to Pay $12,000 to Resolve EEOC Discrimination Finding

Officer Was Subjected to Sexual Harassment, Retaliation and Finally Constructive Discharge, Federal ...

Read More >